High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy
- First Posted Date
- 2011-04-13
- Last Posted Date
- 2014-10-02
- Lead Sponsor
- The New York Eye Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT01334879
- Locations
- 🇺🇸
The New York Eye Cancer Center, New York, New York, United States
Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma
- First Posted Date
- 2008-09-10
- Last Posted Date
- 2012-04-26
- Lead Sponsor
- The New York Eye Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT00750399
- Locations
- 🇺🇸
The New York Eye Cancer Center, New York, New York, United States
Effect of Ranibizumab on Malignant Conjunctival Neoplasia
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- The New York Eye Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT00456495
- Locations
- 🇺🇸
The New York Eye Cancer Center, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath